Research
Association between prenatal alcohol exposure and child socio-emotional development
Appointments
- Director, UCLA Fetal Alcohol Spectrum Disorders Clinic
- Professor, Psychiatry and Biobehavioral Sciences
- Program Director, ABC Child Partial Outpatient Program
- Training Director, Tarjan Center for Developmental Disabilities
Biography
Dr. O’Connor’s current work examines psychosocial and psychiatric risk due to prenatal alcohol exposure. Dr. O’Connor has conducted research on the prevention of alcohol consumption in pregnant women, intervention with children with prenatal alcohol exposure, and medical and allied health education on prevention, diagnosis and treatment.
All of her work has focused on collaborative national initiatives with the long-term goal of developing best practice models to be disseminated on local, state, and national levels.
The overarching emphasis of Dr. O’Connor’s research career has been the development, evaluation, and dissemination of empirically supported assessment and treatment methods for high-risk children.
Publications
- Moumen, A, Masterson, P, O'Connor, MJ, Jackson, SP. Retraction notice to: hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage. Cell. 2024; :. doi: 10.1016/j.cell.2024.10.008. PubMed PMID:39389056 .
- Hakimi, M, Kamsheh, AM, O'Connor, MJ, Loscalzo, S. Case 3: Shock after Gluteal Abscess Incision and Drainage in a 15-month-old Girl. Pediatr Rev. 2024;45 (10):1-5. doi: 10.1542/pir.2023-006019. PubMed PMID:39349859 .
- Lorts, A, VanderPluym, C, Adachi, I, Perry, T, Alexander, PMA, Almond, CS et al.. ACTION-ARC Pediatric and Adult Congenital Heart Disease Ventricular Assist Device Adverse Event Definitions-2023. ASAIO J. 2024; :. doi: 10.1097/MAT.0000000000002288. PubMed PMID:39330959 .
- O'Connor, MJ, Ho, KC, Sriram, N, Fine, KS, Melnick, BA, Bartler, AV et al.. A systematic review on the use of transforming powder dressing for wound care. Int Wound J. 2024;21 (9):e70046. doi: 10.1111/iwj.70046. PubMed PMID:39278842 PubMed Central PMC11402518.
- Herencia-Ropero, A, Llop-Guevara, A, Staniszewska, AD, Domènech-Vivó, J, García-Galea, E, Moles-Fernández, A et al.. The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models. Genome Med. 2024;16 (1):107. doi: 10.1186/s13073-024-01370-z. PubMed PMID:39187844 PubMed Central PMC11348616.